miRNA-101 promotes chondrogenic differentiation in rat bone marrow mesenchymal stem cells

Gao,Feng; Peng,Chuangang; Zheng,Changjun; Zhang,Shanyong; Wu,Minfei

doi:10.3892/etm.2018.6959

miRNA-101 promotes chondrogenic differentiation in rat bone marrow mesenchymal stem cells

Authors:
- Feng Gao
- Chuangang Peng
- Changjun Zheng
- Shanyong Zhang
- Minfei Wu
View Affiliations

Affiliations: Department of Orthopedics, The Second Hospital of Jilin University, Changchun, Jilin 130000, P.R. China
Published online on: November 12, 2018 https://doi.org/10.3892/etm.2018.6959
Pages: 175-180
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Effect and related mechanisms of miR-101 on the chondrogenic differentiation of rat bone marrow mesenchymal stem cells (MSCs) were investigated. The expression level of miR-101 was detected during chondrogenic differentiation. Three groups were established to study the potential function between miR-101 and chondrogenic differentiation: miR-NC group (negative control), miR-101 mimics (BMSCs transfected by miR-101 mimics) and mimics + inhibitor (BMSCs transfected by miR-101 mimics and inhibitor), after the induction of chondrogenic differentiation, the cell viability of MSCs and chondrogenic markers were determined, further, the expression level of Sox9 and Runx2 were detected. In our present research, miR-101 was found upregulated during chondrogenic differentiation of MSCs. Compared with the miR-NC group, the cell viability of MSCs was enhanced and the expression level of chondrogenic markers were respectively gained. The expression level of Sox9 was increased but the expression level of Runx2 was decreased by treatment of miR-101 mimics after induction of chondrogenic differentiation. However, these variations of the indicators were reversed by the intervention using the miR-101 inhibitor. Collectively, our research revealed promotion function of miR-101 on chondrogenic differentiation of MSCs, indicating that miR-101 could be a potential therapeutic strategy for the treatment of osteoarthritis (OA).

View Figures

View References

1	Goldring MB and Goldring SR: Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci. 1192:230–237. 2010. View Article : Google Scholar : PubMed/NCBI
2	Reynard LN and Loughlin J: Insights from human genetic studies into the pathways involved in osteoarthritis. Nat Rev Rheumatol. 9:573–583. 2013. View Article : Google Scholar : PubMed/NCBI
3	Blagojevic M, Jinks C, Jeffery A and Jordan KP: Risk factors for onset of osteoarthritis of the knee in older adults: A systematic review and meta-analysis. Osteoarthritis Cartilage. 18:24–33. 2010. View Article : Google Scholar : PubMed/NCBI
4	Qi Y, Feng G and Yan W: Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Mol Biol Rep. 39:5683–5689. 2012. View Article : Google Scholar : PubMed/NCBI
5	Guermazi A, Niu J, Hayashi D, Roemer FW, Englund M, Neogi T, Aliabadi P, McLennan CE and Felson DT: Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: Population based observational study (Framingham Osteoarthritis Study). BMJ. 29:e53392012. View Article : Google Scholar
6	Kao YJ, Ho J and Allen CR: Evaluation and management of osteochondral lesions of the knee. Phys Sportsmed. 39:60–69. 2011. View Article : Google Scholar : PubMed/NCBI
7	Longo UG, Petrillo S, Franceschetti E, Berton A, Maffulli N and Denaro V: Stem cells and gene therapy for cartilage repair. Stem Cells Int. 2012:1683852012. View Article : Google Scholar : PubMed/NCBI
8	Sampson S, Botto-van Bemden A and Aufiero D: Stem cell therapies for treatment of cartilage and bone disorders: Osteoarthritis, avascular necrosis, and non-union fractures. PM R. 7 Suppl 4:S26–S32. 2015. View Article : Google Scholar : PubMed/NCBI
9	Houdek MT, Wyles CC, Martin JR and Sierra RJ: Stem cell treatment for avascular necrosis of the femoral head: Current perspectives. Stem Cells Cloning. 7:65–70. 2014.PubMed/NCBI
10	Wei ZJ, Liu J and Qin J: miR-138 suppressed the progression of osteoarthritis mainly through targeting p65. Eur Rev Med Pharmacol Sci. 21:2177–2184. 2017.PubMed/NCBI
11	Le LT, Swingler TE, Crowe N, Vincent TL, Barter MJ, Donell ST, Delany AM, Dalmay T, Young DA and Clark IM: The microRNA-29 family in cartilage homeostasis and osteoarthritis. J Mol Med (Berl). 94:583–596. 2016. View Article : Google Scholar : PubMed/NCBI
12	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
13	Han J, Yang T, Gao J, Wu J, Qiu X, Fan Q and Ma B: Specific microRNA expression during chondrogenesis of human mesenchymal stem cells. Int J Mol Med. 25:377–384. 2010.PubMed/NCBI
14	Lahiji A, Sohrabi A, Hungerford DS and Frondoza CG: Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res. 51:586–595. 2000. View Article : Google Scholar : PubMed/NCBI
15	Cucchiarini M, de Girolamo L, Filardo G, Oliveira JM, Orth P, Pape D and Reboul P: Basic science of osteoarthritis. J Exp Orthop. 3:222016. View Article : Google Scholar : PubMed/NCBI
16	Kawaguchi H: Regulation of osteoarthritis development by Wnt-beta-catenin signaling through the endochondral ossification process. J Bone Miner Res. 24:8–11. 2009. View Article : Google Scholar : PubMed/NCBI
17	Guérit D, Philipot D, Chuchana P, Toupet K, Brondello JM, Mathieu M, Jorgensen C and Noël D: Sox9-regulated miRNA-574-3p inhibits chondrogenic differentiation of mesenchymal stem cells. PLoS One. 8:e625822013. View Article : Google Scholar : PubMed/NCBI
18	Cairns DM, Liu R, Sen M, Canner JP, Schindeler A, Little DG and Zeng L: Interplay of Nkx3.2, Sox9 and Pax3 regulates chondrogenic differentiation of muscle progenitor cells. PLoS One. 7:e396422012. View Article : Google Scholar : PubMed/NCBI
19	Cao L, Yang F, Liu G, Yu D, Li H, Fan Q, Gan Y, Tang T and Dai K: The promotion of cartilage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells. Biomaterials. 32:3910–3920. 2011. View Article : Google Scholar : PubMed/NCBI
20	Cucchiarini M, Orth P and Madry H: Direct rAAV SOX9 administration for durable articular cartilage repair with delayed terminal differentiation and hypertrophy in vivo. J Mol Med (Berl). 91:625–636. 2013. View Article : Google Scholar : PubMed/NCBI
21	Hargus G, Kist R, Kramer J, Gerstel D, Neitz A, Scherer G and Rohwedel J: Loss of Sox9 function results in defective chondrocyte differentiation of mouse embryonic stem cells in vitro. Int J Dev Biol. 52:323–332. 2008. View Article : Google Scholar : PubMed/NCBI
22	de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S and Huang W: Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 19:389–394. 2000. View Article : Google Scholar : PubMed/NCBI
23	Ito Y and Miyazono K: RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev. 13:43–47. 2003. View Article : Google Scholar : PubMed/NCBI
24	Marie PJ: Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys. 473:98–105. 2008. View Article : Google Scholar : PubMed/NCBI
25	Shen Q and Christakos S: The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J Biol Chem. 280:40589–40598. 2005. View Article : Google Scholar : PubMed/NCBI
26	Hassan MQ, Tare RS, Lee SH, Mandeville M, Morasso MI, Javed A, van Wijnen AJ, Stein JL, Stein GS and Lian JB: BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J Biol Chem. 281:40515–40526. 2006. View Article : Google Scholar : PubMed/NCBI